LAURA LACK: Open Payments
NPI 1275241747 · DUNKIRK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$426 in 23 payments from 13 companies in 2025. Trend: 2023 $335 · 2024 $479 · 2025 $426
Food & beverage: $426
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $76 |
| Exact Sciences Corporation | 3 | $68 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| Boston Scientific Corporation | 2 | $38 |
| PFIZER INC. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $30 |
| ViiV Healthcare Company | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $19 |
Products named: UBRELVY, Cologuard Collection Kit, WATCHMAN FLX, TRELEGY ELLIPTA, CAPLYTA, SHINGRIX, The Cologuard Plus Collection Kit, CABENUVA.
Industry payments across NY — which companies pay providers there.
